Product Images Levetiracetam
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 14 images provide visual information about the product associated with Levetiracetam NDC 43547-223 by Solco Healthcare Us, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This appears to be a figure showing the Responder Rate (>50% Reduction From Baseline) for Study 1. It shows the percentages of responders for the Placebo group (N=95) and the Levetiracetam groups taking 1000 mg/day (N=37) and 3000 mg/day (N=101). There is also a note indicating that one of the groups had a statistically significant difference from the placebo group.*
The text provides a figure, labeled as Figure 2, which shows the Responder Rate (>50% Reduction From Baseline) in Study 2, specifically in Period A. There are percentages ranging from 0% to 40% on the y-axis, and two groups identified on the x-axis, Placebo and Levetiracetam, which had different dosages (1000 moj/day and 2000 moj/day) and number of participants in each group (N=111, N=106, N=105). The text also indicates that there were statistically significant results for Levetiracetam versus placebo.*
The figure is showing the Responder Rate (>50% Reduction From Baseline) in Study 3 for two drugs, Placebo and Levetiracetam. Levetiracetam is given at a dose of 3000 mg/day (N=180) and Placebo at N=104. The Responder Rate is shown on the Y-axis ranging from 0% to 45%. The X-axis has the percentages ranging from 0% to 50%, in increments of 5% and the two drugs are on the X-axis. The statistical significance of Levetiracetam versus Placebo is also mentioned in the footnote.*
The graph in Figure 4 of the study shows the responder rate (2509 reduction from baseline) in two groups of patients receiving placebo or Levetiracetam. Levetiracetam showed a statistically significant difference compared to the placebo group. The vertical axis represents the percentage of patients, while the horizontal axis represents different response rates.*
The figure 6 shows the responder rate for a 50% reduction from the baseline in PGTC seizures frequency per week for study 7. The placebo (N=84) and Levetiracetam groups were compared, where Levetiracetam group had a statistically significant difference compared to placebo (P < 0.05). The responder rate for Levetiracetam group was 72.2% compared to 45.2% for placebo.*
Dipense na gt igh reitantcoianer R only. This is a medication expressed in milligrams of levetiracetam. Store between 20-25°C (68-77°F) unless permitted to be kept between 15-30°C (53-86°F). It is manufactured by Zhejang Hushai Pharmaceutical Co. Ltd in China and distributed by Soiotethowe US LLC in Somerset, NJ 06473, USA. This information provides a brief description of the medication, its format, and guidelines on appropriate storing.*
This is a medicine labeling text for Levetiracetam Tablets, USP. It contains information such as the recommended storage conditions, dosage instructions, and the manufacturer's details. The tablets are contained in a child-resistant and airtight container and should be stored at a temperature between 15-30°C. The medication should be dispensed along with a medication guide to each patient. The text also provides details of the manufacturer and the composition of the drug. There is a note about an uncoated area on the box.*
This is a description of a medication bottle containing Levetiracetam tablets. The container is child-resistant and tamper-resistant. Each tablet contains 1000 mg of the medication. The packaging includes information on dosage. The medication should be stored at a temperature between 15-30°C (53-86°F). The manufacturer is S Zbejong Huahai Pharmaceutical Co. Ltd in China, and it is distributed by Soco Healthcare US, LLC in New Jersey. The product comes with a medication guide.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.